About US
Contact us
-
European Commission approves Pierre Fabre’s Hemangiol for infantile hemangioma treatmentPierre Fabre Dermatologie Laboratories has received paediatric use marketing authorisation from the European Commission for Hemangiol (propranolol), indicated for treatment of proliferating infantile2014/5/7
-
Teva’s Synribo for injection receives FDA approval for home administrationTeva Pharmaceutical has obtained US Food and Drug Administration (FDA) approval for Synribo (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration for patients2014/5/7
-
Merck and Endocyte Announce Independen​t DSMB Recommends Vintafolid​e PROCEED Phase III Trial be StoppedMerck(known as MSD outside the US and Canada) and Endocyte, Inc. haveannounced that the Data Safety Monitoring Board (DSMB) of the PROCEED trial has completed a pre-specified, interim futility analysi2014/5/6
-
Second Genome Enters Into Agreement with Pfizer Inc. on Microbiome Research Initiative in ObesitySecond Genome announced has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic2014/5/6
-
Otsuka's tuberculosis drug Deltyba secures marketing approval in EUJapan-based Otsuka Pharmaceutical has received marketing authorisation from the European Commission for Deltyba (delamanid) to use as part of an appropriate combination regimen for pulmonary multidrug2014/5/5
-
Allergan's Botox gets positive opinion from Irish Medicines BoardAllergan has received a positive opinion for Botox (Botulinum Toxin Type A) from the Irish Medicines Board serving as reference member state in the mutual recognition procedure (MRP) for treatment of2014/5/5
-
GSK's Incruse Ellipta gets FDA approval to treat airflow obstruction in COPD patientsGlaxoSmithKline (GSK) has received US Food and Drug Administration (FDA) approval for Incruse Ellipta (umeclidinium) as an anticholinergic indicated for the once-daily, maintenance treatment of airflo2014/5/4
-
US FDA grants priority review for AstraZeneca's ovarian cancer drug olaparibThe US Food and Drug Administration (FDA) has granted priority review for AstraZeneca's new drug application (NDA) of olaparib for treatment of ovarian cancer. Olaparib is an oral poly ADP-ribose pol2014/5/4
-
Novozymes' Half-Life Extension Technology Reaches Landmark Milestone as GSK's Albiglutide is Granted FDA Marketing ApprovalFDA has granted marketing approval to GlaxoSmithKline's new Type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses Novozymes' Veltis technology to achieve an extended half-l2014/4/30
-
Janssen's type 2 diabetes drug Vokanamet gets European Commission approval in EUJanssen-Cilag International (Janssen) has received approval from the European Commission (EC) for use of Vokanamet in the European Union (EU) as a treatment for adults with type 2 diabetes mellitus to2014/4/30